| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153172 | American Heart Journal | 2005 | 5 Pages |
Abstract
In this population-based study of recently revascularized elderly patients, we observed health benefits associated with the use of cholesterol-lowering medications of similar size to those seen in randomized clinical trials. The translation of these benefits from clinical trials to a nonselected population of revascularized patients emphasizes the importance of this aspect of secondary prevention in clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
James M. MD, PhD, Paul MD, MSc, Chantal PhD,